Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Phase II study of preoperative chemotherapy with docetaxel, oxaliplatin and S-1 in gastric cancer with extensive lymph node metastasis (JCOG1704).
Sato Y, Kurokawa Y, Doki Y, Mizusawa J, Tanaka K, Katayama H, Boku N, Yoshikawa T, Terashima M; Stomach Cancer Study Group/Japan Clinical Oncology Group. Sato Y, et al. Among authors: katayama h. Future Oncol. 2020 Feb;16(4):31-38. doi: 10.2217/fon-2019-0528. Epub 2020 Jan 10. Future Oncol. 2020. PMID: 31920105 Clinical Trial.
A Phase II study of systemic chemotherapy with docetaxel, cisplatin, and S-1 (DCS) followed by surgery in gastric cancer patients with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1002.
Katayama H, Ito S, Sano T, Takahari D, Mizusawa J, Boku N, Tsuburaya A, Terashima M, Sasako M; Stomach Cancer Study Group of the Japan Clinical Oncology Group. Katayama H, et al. Jpn J Clin Oncol. 2012 Jun;42(6):556-9. doi: 10.1093/jjco/hys054. Epub 2012 Apr 23. Jpn J Clin Oncol. 2012. PMID: 22525210 Clinical Trial.
Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
Fujita S, Akasu T, Mizusawa J, Saito N, Kinugasa Y, Kanemitsu Y, Ohue M, Fujii S, Shiozawa M, Yamaguchi T, Moriya Y; Colorectal Cancer Study Group of Japan Clinical Oncology Group. Fujita S, et al. Lancet Oncol. 2012 Jun;13(6):616-21. doi: 10.1016/S1470-2045(12)70158-4. Epub 2012 May 15. Lancet Oncol. 2012. PMID: 22591948 Clinical Trial.
Short-term surgical outcomes from a randomized controlled trial to evaluate laparoscopic and open D3 dissection for stage II/III colon cancer: Japan Clinical Oncology Group Study JCOG 0404.
Yamamoto S, Inomata M, Katayama H, Mizusawa J, Etoh T, Konishi F, Sugihara K, Watanabe M, Moriya Y, Kitano S; Japan Clinical Oncology Group Colorectal Cancer Study Group. Yamamoto S, et al. Among authors: katayama h. Ann Surg. 2014 Jul;260(1):23-30. doi: 10.1097/SLA.0000000000000499. Ann Surg. 2014. PMID: 24509190 Clinical Trial.
A randomized controlled trial comparing laparoscopic surgery with open surgery in palliative resection of primary tumor in incurable Stage IV colorectal cancer: Japan Clinical Oncology Group Study JCOG 1107 (ENCORE trial).
Inomata M, Akagi T, Katayama H, Kimura A, Mizusawa J, Etoh T, Yamaguchi S, Ito M, Kinugasa Y, Saida Y, Hasegawa H, Ota M, Kanemitsu Y, Shimada Y, Kitano S; Colorectal Cancer Study Group (CCSG) of Japan Clinical Oncology Group. Inomata M, et al. Among authors: katayama h. Jpn J Clin Oncol. 2014 Nov;44(11):1123-6. doi: 10.1093/jjco/hyu115. Epub 2014 Aug 25. Jpn J Clin Oncol. 2014. PMID: 25156683 Clinical Trial.
A randomized controlled Phase II/III study comparing endoscopic balloon dilation combined with steroid injection versus radial incision and cutting combined with steroid injection for refractory anastomotic stricture after esophagectomy: Japan Clinical Oncology Group Study JCOG1207.
Kataoka K, Aoyama I, Mizusawa J, Eba J, Minashi K, Yano T, Tanaka M, Hanaoka N, Katayama H, Takizawa K, Fukuda H, Muto M; Gastrointestinal Endoscopy Study Group (GIESG) of the Japan Clinical Oncology Group. Kataoka K, et al. Among authors: katayama h. Jpn J Clin Oncol. 2015 Apr;45(4):385-9. doi: 10.1093/jjco/hyv006. Epub 2015 Jan 27. Jpn J Clin Oncol. 2015. PMID: 25628348 Clinical Trial.
A randomized controlled Phase III trial comparing 2-weekly docetaxel combined with cisplatin plus fluorouracil (2-weekly DCF) with cisplatin plus fluorouracil (CF) in patients with metastatic or recurrent esophageal cancer: rationale, design and methods of Japan Clinical Oncology Group study JCOG1314 (MIRACLE study).
Kataoka K, Tsushima T, Mizusawa J, Hironaka S, Tsubosa Y, Kii T, Shibuya Y, Chin K, Katayama H, Kato K, Fukuda H, Kitagawa Y; Japan Esophageal Oncology Group/Japan Clinical Oncology Group. Kataoka K, et al. Among authors: katayama h. Jpn J Clin Oncol. 2015 May;45(5):494-8. doi: 10.1093/jjco/hyv012. Epub 2015 Feb 2. Jpn J Clin Oncol. 2015. PMID: 25646357 Clinical Trial.
1,161 results